- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tibet Rhodiola Pharmaceutical Holding Co (600211)
Tibet Rhodiola Pharmaceutical Holding Co stock price live, this page displays SS 600211 stock exchange data. View the 600211 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tibet Rhodiola Pharmaceutical Holding Co real time stock price chart below.
What Is the Tibet Rhodiola Pharmaceutical Holding Co Stock Price Today?
The Tibet Rhodiola Pharmaceutical Holding Co stock price today is 36,35.
What Is the Stock Symbol for Tibet Rhodiola Pharmaceutical Holding Co?
The stock symbol for Tibet Rhodiola Pharmaceutical Holding Co is "600211."
What Stock Exchange Does Tibet Rhodiola Pharmaceutical Holding Co Trade On?
Tibet Rhodiola Pharmaceutical Holding Co is listed and trades on the Shanghai stock exchange.
Is Tibet Rhodiola Pharmaceutical Holding Co a Good Stock to Buy?
Determining whether Tibet Rhodiola Pharmaceutical Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600211 quote. (ISIN: CNE000000ZW7)
What Is the Tibet Rhodiola Pharmaceutical Holding Co Stock Price Today?
The Tibet Rhodiola Pharmaceutical Holding Co stock price today is 36,35.
What Is the Stock Symbol for Tibet Rhodiola Pharmaceutical Holding Co?
The stock symbol for Tibet Rhodiola Pharmaceutical Holding Co is "600211."
What Stock Exchange Does Tibet Rhodiola Pharmaceutical Holding Co Trade On?
Tibet Rhodiola Pharmaceutical Holding Co is listed and trades on the Shanghai stock exchange.
Is Tibet Rhodiola Pharmaceutical Holding Co a Good Stock to Buy?
Determining whether Tibet Rhodiola Pharmaceutical Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600211 quote. (ISIN: CNE000000ZW7)
Shanghai
Currency in CNY
36.35
+0.59(+1.65%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
35.69
36.50
52 wk Range
34.80
49.94
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
35.6936.50
52 wk Range
34.8049.94
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.56%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.56%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600211 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 4 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
0,98 / --
Revenue / Forecast
830,89M / --
Compare 600211 to Peers and Sector
Metrics to compare | 600211 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600211PeersSector | |
|---|---|---|---|---|
P/E Ratio | 11.8x | 12.2x | −0.3x | |
PEG Ratio | −10.67 | 0.03 | 0.00 | |
Price/Book | 3.0x | 1.2x | 2.6x | |
Price / LTM Sales | 4.0x | 1.3x | 3.0x | |
Upside (Analyst Target) | - | 27.6% | 58.6% | |
Fair Value Upside | Unlock | 18.9% | 8.4% | Unlock |
Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Tibet Pharma (600211) Stock Price Today?
The Tibet Pharma stock price today is 36,35 CNY.
What Stock Exchange Does Tibet Pharma Trade On?
Tibet Pharma is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Tibet Pharma?
The stock symbol for Tibet Pharma is "600211."
Does Tibet Pharma Pay Dividends? What’s The Current Dividend Yield?
The Tibet Pharma dividend yield is 5.56%.
What Is the Tibet Pharma Market Cap?
As of today, Tibet Pharma market cap is 11,57B CNY.
What Is Tibet Pharma's Earnings Per Share (TTM)?
The Tibet Pharma EPS (TTM) is 3,06.
When Is the Next Tibet Pharma Earnings Date?
Tibet Pharma will release its next earnings report on Apr 24, 2026.
From a Technical Analysis Perspective, Is 600211 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Tibet Pharma Stock Split?
Tibet Pharma has split 4 times.
How Many Employees Does Tibet Pharma Have?
Tibet Pharma has 671 employees.
What is the current trading status of Tibet Pharma (600211)?
As of Oct 03, 2026, Tibet Pharma (600211) is trading at a price of 36,35 CNY, with a previous close of 36,35 CNY. The stock has fluctuated within a day range of 35,69 CNY to 36,50 CNY, while its 52-week range spans from 34,80 CNY to 49,94 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.